New flexible sensor technology transforms ordinary diapers into medical monitoring devices, enabling real-time tracking of ...
AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...
AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...
LR-19155 is under clinical development by LG Chem and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData, Phase I drugs for Non-Small Cell Lung Cancer have an 80% phase ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.